Medication use in children admitted to a general hospital

Camila Fernandes Martins, Marcela Fornari Uberti, Thainá Paola Warpechowski, Fabiana Schuelter-Trevisol, Daisson José Trevisol

Abstract


*** Medication use in children admitted to a general hospital ***

AIMS: To describe the profile of medications used in children admitted to a general hospital.

METHODS: A cross-sectional study was conducted with children aged 0 to 12 years, admitted to the Hospital Nossa Senhora da Conceição, in Tubarão, state of Santa Catarina, Brazil, between July 2013 and July 2014. The following data were collected: f age, sex, length of hospital stay, International Classification of Diseases codes for hospitalization, and medications used. The Anatomical Therapeutic Chemical classification system was used for the medications.

RESULTS: The medical records of 1,603 children aged up to 12 years were analyzed. The hospital stay ranged from one to 115 days. The number of medications per admission ranged from one to 77, with an average of 9.84 medications per patient. A total of 211 different types of medications were used, most of which were classified as analgesic with central nervous system activity. Tonsillar hypertrophy and adenoid hypertrophy were the most prevalent disorders diagnosed among the 303 different International Classification of Diseases codes found in this study. Seven types of unlicensed medications and 23 drugs with some kind of restriction for pediatric use were prescribed.

CONCLUSIONS: The average number of medications was high in hospitalized children, and the prescription of unlicensed drugs and those with some kind of restriction for pediatric use was an important factor. These data suggest poor attention to the risks and benefits of medication use in children – a relevant issue that requires continuous and intensive surveillance by different health professionals .


 


Keywords


drug utilization; pharmacoepidemiology; child; medication errors.

References


Ferreira TR., Lopes LC. Análise do uso de analgésicos, antipiréticos e anti-inflamatórios não esteroides em prescrição pediátrica. J Pediatr (Rio J). 2016;92(1):1-7. http://dx.doi.org/10.1016/j.jped.2015.04.007

Carvalho ML. O desafio do uso off label de medicamentos. Rev Paul Pediatr. 2016;34(1):1-2. https://doi.org/10.1016/j.rpped.2015.10.001

Costa PQ, Rey LC, Coelho HLL. Carência de preparações medicamentosas para uso em crianças no Brasil. J Pediatr. 2009;85:229-35. https://doi.org/10.1590/S0021-75572009000300008

U.S. Department of Health & Human Services. Food and Drug Administration Modernization Act (FDAMA) of 1997 [Internet]. United States 1997 [cited 2016 Oct 25] Available from: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFood-DrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDAMA/ucm089179.htm

U.S. Department of Health & Human Services. Food and Drug Administration. Significant Amendments to the FD&C Act—Best Pharmaceuticals for Children Act [Internet]. United States 2016 [cited 2016 Oct 25] Available from: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeti-cActFDCAct/SignificantAmendmentstotheFDCAct/ucm148011.htm

U.S. Department of Health & Human Services. Food and Drug Administration. Pediatric Research Equity Act of 2003 [Internet]. United States 2013 [cited 2016 Oct 25] Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM077853.pdf

Shaddy RE, Denne SC; Committee on Drugs and Committee on Pediatric Research. Clinical report- guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics. 2010 Apr;125(4):850-60. https://doi.org/10.1542/peds.2010-0082

Corny J, Lebel D, Bailey B, Bussières JF. Unlicensed and off-label drug use in children before and after pediatric governmental initiatives. J Pediatr Pharmacol Ther. 2015 Jul-Aug;20(4):316-28. http://dx.doi.org/10.5863/1551-6776-20.4.316

Official Journal of the European Union. On Medicinal Products for Paediatric Use [Internet]. Europ 2006 [cited 2016 Oct 25] Available from: http://ec.europa.eu/health/files/eudralex/vol-1/reg_2006_1901/reg_2006_1901_en.pdf

Loureiro CV, Néri EDR, Dias HI, Mascarenhas MBJ, Fontteles MMF. Uso de medicamentos off-Label ou não licenciados para pediatria em hospital público brasileiro. Rev Bras Farm. 2013;4(1):17-21.

Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J, Trotta EA. Identificação de medicamentos "não apropriados para crianças" em prescrições de unidade de tratamento intensivo pediátrica. J Pediatr. 2003;79(5):397-402. https://doi.org/10.2223/JPED.1069

Meiners MMMA, Bergsten-Mendes G. Prescrição de medicamentos para crianças hospitalizadas: como avaliar a qualidade?. Rev Assoc Med Bras. 2001;47(4):332. https://doi.org/10.1590/S0104-42302001000400036

Ferreira LA, Ibiapina CC, Machado MGP, Fagundes EDT. A alta prevalência de prescrições de medicamentos off-label e não licenciados em unidade de terapia intensiva pediátrica brasileira. Rev Assoc Med Bras. 2012;58(1):82-7. https://doi.org/10.1016/S0104-4230(12)70159-8

Santos DB, Coelho HL. Reações adversas a medicamentos em pediatria: uma revisão sistemática de estudos prospectivos. Rev Bras Saúde Matern Infant. 2004;4:341-9. https://doi.org/10.1590/S1519-38292004000400002

Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in pediatrics: a review of the literature. Fundam Clin Pharmacol. 2003 Feb;17(1):125-31 https://doi.org/10.1046/j.1472-8206.2003.00123.x

Gonçalvez ACS, Caixeta CM, Reis AMM. Análise da utilização de medicamentos antimicrobianos sistêmicos em crianças e adolescentes em dois hospitais de ensino. Rev Ciênc Farm Básica Apl. 2009;30:49-54.

Tonello P, Andriguetti LH, Perassolo MS, Ziulkoski AL. Avaliação do uso de medicamentos em uma unidade pediátrica de um hospital privado do sul do Brasil. Rev Ciênc Farm Básica Apl. 2013;34(1):101-8.

Cunha MCN, Zorzatto JR, Castro LLC. Avaliação do uso de medicamentos na rede pública municipal de saúde de Campo Grande/MS. Rev Bras Ciênc Farm. 2005;38(2):215-27. https://doi.org/10.1590/S1516-93322002000200011

Carvalho DC. Uso de medicamentos em crianças de 0 a 6 anos matriculadas em creches de Tubarão, Santa Catarina. Rev Paul Pediatr. 2008;26(3):238-44. https://doi.org/10.1590/S0103-05822008000300007

Santos DB, Batista LA, Lima LDA, Coêlho HLL. Revisão sistemática de estudos descritivos sobre o uso de medicamentos em crianças hospitalizadas. Rev Bras Farm. 2011;2(1):26-30.

Ferreira VOG, Melnikov P, Toffoli-Kadri MC. Nível de entendimento de prescrições medicamentosas pediátricas em unidades básicas de saúde. Rev Bras Saúde Mater Infant. 2011;11(3):249-56. https://doi.org/10.1590/S1519-38292011000300005

Sano PY, Masotti RR, Santos AAC, Cordeiro JA. Avaliação do nível de compreensão da prescrição pediátrica. J Pediatr. 2002;78(2):140-5. https://doi.org/10.1590/s0021-75572002000200013

Martins TSS, Silvino ZR, Silva LR. Eventos adversos na terapia farmacológica pediátrica: revisão integrativa da literatura. Rev Bras Enferm. 2011;64(4):745-50. https://doi.org/10.1590/S0034-71672011000400018

Mendes MCPM, Pinheiro RO, Avelar KES, Teixeira JL, Silva GMS. História da farmacologia no Brasil. Rev Bras Farm. 2008;89(3):246-51.

World Health Organization. Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2013. Oslo: WHO; 2012.

Agência Nacional de Vigilância Sanitária - Anvisa. Como a Anvisa vê o uso off label de medicamentos [Internet]. Brasília; 2005 [updated 2009 Jul 15; cited 2016 Jul 12]. Available from: http://www.anvisa.gov.br/medicamentos/registro/registro_offlabel.htm

World Health Organization. WHO model list of essential medicines for children [Internet]. 2013 [updated 2015 Apr; cited 2015 May 9]. Avaiable from: http://www.who.int/medicines/publications/essentialmedicines/en/

't Jong GW, Vulto AG, de Hoog M, Schimmel KJ, Tibboel D, van den Anker JN. A survey of the use of off-label and unlicensed drugs in a dutch children's hospital. Pediatrics. 2001 Nov;108(5):1089-93. https://doi.org/10.1542/peds.108.5.1089

Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J, Trotta EA. Identificação de medicamentos "não apropriados para crianças" em prescrições de unidade de tratamento intensivo pediátrica. J Pediatr. 2003;79(5):397-402. https://doi.org/10.2223/JPED.1069

Gonçalves MG, Heineck I. Frequência de prescrições de medicamentos off label e não licenciados para pediatria na atenção primária à saúde em município do sul do Brasil. Rev Paul Pediatr. 2016;34(1):e11-17. https://doi.org/10.1016/j.rpped.2015.06.008

Carvalho CG, Ribeiro MR, Bonilha MM, Fernandes JM, Procianoy RS, Silveira RC. Uso de medicamentos off-label e não licenciados em unidade de tratamento intensivo neonatal e sua associação com escores de gravidade. J Pediatr (RioJ). 2012;88(6):e465-470. http://dx.doi.org/10.1590/S0021-75572012000600004

Oliveira BRG, Viera CS, Collet N, Lima RAG. Causas de hospitalização no SUS de crianças de zero a quatro anos no Brasil. Rev Bras Epidemiol. 2010;13(2): e268-77. https://doi.org/10.1590/S1415-790X2010000200009

Ferrer APS. Estudo das causas de internação hospitalar das crianças de 0 a 9 anos de idade no município de São Paulo [dissertação]. São Paulo: USP; 2009. https://doi.org/10.11606/d.5.2009.tde-23022010-145034

Oliveira BRG, Viera CS, Colett N, Lima RAG. Causas de hospitalização no SUS de crianças de zero a quatro anos no Brasil. Rev Bras Epidemiol. 2010;13(2):268-77. https://doi.org/10.1590/S1415-790X2010000200009

Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini C, Raffaelli MA, Rocchi F, Bonati M, Jong G, Hoog M, Anker J. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000 Jan 8;320(7227):79-82. https://doi.org/10.1136/bmj.320.7227.79

Saiyed MM, Lalwani T, Rana D. Off-label medicine use in pediatric inpatients: a prospective observational study at a tertiary care hospital in India. Int J Pediatr. 2014;2014:e6.

Al Balushi KA, Al-Sawafi F, Al-Ghafri F, Al-Zakwani I. Drug utilization pattern in an Omani pediatric population. J Basic Clin Pharm. 2013;4(3):68–72. https://doi.org/10.4103/0976-0105.118808

Agência Nacional de Vigilância Sanitária (BR). Dipirona monoidratada, bula [Internet]. Brasília [cited 2016 Nov 11] Available from: http://www.anvisa.gov.br/datavisa/fila_bula/frmVisualizarBula.asp?pNuTransacao=1022322014&pIdAnexo=1961219

Maluf E, Hamerschlak N, Cavalcanti AB, Júnior AA, Eluf-Neto J, Falcão RP, Lorand-Metze IG, Goldenberg D, Santana CL, Rodrigues DO, Passos LN, Rosenfeld LG, Pitta M, Loggetto S, Ribeiro AA, Velloso ED, Kondo AT, Coelho EO, Pintão MC, de Souza HM, Borbolla JR, Pasquini R. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study. Haematologica. 2009 Sep;94(9):1220-6. https://doi.org/10.3324/haematol.2008.002642

Taverner D, Latte GJ. Withdrawn: Nasal decongestants for the common cold. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001953.

De Sutter AI, Lemiengre M, Campbell H. Withdrawn: Antihistamines for the common cold. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001267.

Chang AB, Peake J, McElrea MS. Anti-histamines for prolonged non-specific cough in children. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005604. https://doi.org/10.1002/14651858.cd005604.pub3

Shaikh N, Wald ER, Pi M. Decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD007909. https://doi.org/10.1002/14651858.cd007909.pub2

Moraes CG, Mengue SS, Tavares NUL, Pizzol TSD. Utilização de medicamentos entre crianças de zero a seis anos:um estudo de base populacional no sul do Brasil. Ciênc Saúde Coletiva. 2013;18(12):3585-93. https://doi.org/10.1590/S1413-81232013001200015

Gonçalves MG, Heineck I. Frequency of prescriptions of off-label drugs and drugs not approved for pediatric use in primary health care in a southern municipality of Brazil. Rev Paul Pediatr. 2016;34(1):e11-17. https://doi.org/10.1016/j.rpped.2015.06.008

Dos Santos L, Heineck I. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications. Farm Hosp. 2012;36(4):180-6. https://doi.org/10.1016/j.farma.2010.12.008

Clavenna A, Bonati M. Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol. 2009 Aug;65(8):749-55. https://doi.org/10.1007/s00228-009-0679-7

Santos DB, Barreto ML, Coelho HL. Drug use and associated factors in children living in poor areas. Rev Saude Publica. 2009 Oct;43(5):768-78. https://doi.org/10.1590/S0034-89102009000500005

Oliveira EA, Bertoldi AD, Domingues MR, Santos IS, Barros AJ. Medicine use from birth to age two years: the 2004 Pelotas (Brazil) Birth Cohort study. Rev Saude Publica. 2010 Aug;44(4):591-600. https://doi.org/10.1590/S0034-89102010000400002

Thompson DF, Heflin NR, Frequency and appropriateness of drug prescribing for unlabeled uses in pediatric patients. Am J Hosp Pharm. 1987 Apr;44(4):792-4.

Ministério da Saúde (BR). Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Assistência Farmacêutica e Insumos Estratégicos; Liberato E, Souza PM, Silveira CAN, Lopes LC. Formulário Terapêutico Nacional 2008. Brasília: RENAME; 2006.




DOI: http://dx.doi.org/10.15448/1980-6108.2017.2.25208

e-ISSN: 1980-6108 | ISSN-L: 1806-5562


Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.